Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Weigert

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Deutsche Medizinische Wochenschrift (1946)|May 15, 2024
[Lymphom]Oliver Weigert
Blood|July 31, 2020
The different flavors and splices of MCLOliver Weigert
Journal for Immunotherapy of Cancer|January 25, 2017
It's a long way to the top (if you want to personalize immunotherapy)Sarah Haebe, Oliver Weigert
Leukemia & Lymphoma|November 21, 2008
Prognosis of mantle cell lymphoma: is it all about proliferation?Oliver Weigert, Martin Dreyling
Blood|August 9, 2017
The promises and challenges of using gene mutations for patient stratification in follicular lymphomaOliver Weigert, David M Weinstock
Blood|August 8, 2012
The evolving contribution of hematopoietic progenitor cells to lymphomagenesisOliver Weigert, David M Weinstock
Biologics : Targets & Therapy|June 10, 2010
Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principleAndreas Rank, Oliver Weigert, Helmut Ostermann
Deutsche Medizinische Wochenschrift (1946)|May 15, 2024
[Targeted therapies in the management of malignant lymphoma - is the end of conventional chemotherapy near?]Johannes C Hellmuth, Raphael Koch, Oliver Weigert
Blood Advances|August 10, 2023
The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomasItziar Salaverria, Oliver Weigert, Leticia Quintanilla-Martinez
Drugs|August 9, 2007
Current management of mantle cell lymphomaOliver Weigert, Michael Unterhalt, Wolfgang Hiddemann, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Deutsche Medizinische Wochenschrift (1946)|May 15, 2024
[Lymphom]Oliver Weigert
Blood|July 31, 2020
The different flavors and splices of MCLOliver Weigert
Journal for Immunotherapy of Cancer|January 25, 2017
It's a long way to the top (if you want to personalize immunotherapy)Sarah Haebe, Oliver Weigert
Leukemia & Lymphoma|November 21, 2008
Prognosis of mantle cell lymphoma: is it all about proliferation?Oliver Weigert, Martin Dreyling
Blood|August 9, 2017
The promises and challenges of using gene mutations for patient stratification in follicular lymphomaOliver Weigert, David M Weinstock
Blood|August 8, 2012
The evolving contribution of hematopoietic progenitor cells to lymphomagenesisOliver Weigert, David M Weinstock
Biologics : Targets & Therapy|June 10, 2010
Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principleAndreas Rank, Oliver Weigert, Helmut Ostermann
Deutsche Medizinische Wochenschrift (1946)|May 15, 2024
[Targeted therapies in the management of malignant lymphoma - is the end of conventional chemotherapy near?]Johannes C Hellmuth, Raphael Koch, Oliver Weigert
Blood Advances|August 10, 2023
The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomasItziar Salaverria, Oliver Weigert, Leticia Quintanilla-Martinez
Drugs|August 9, 2007
Current management of mantle cell lymphomaOliver Weigert, Michael Unterhalt, Wolfgang Hiddemann, et al.
Pageof 8